Company Filing History:
Years Active: 2014-2019
Title: The Innovative Contributions of Philip P Resig
Introduction: Philip P Resig, an accomplished inventor based in Mason, OH, has made notable advancements in the field of medical devices. With two patents to his name, Resig's innovations focus on improving tissue occlusion technologies, demonstrating his commitment to enhancing patient care and outcomes.
Latest Patents: Philip P Resig holds two significant patents, both related to clip applicators. The first patent describes an occlusion assembly that comprises a tissue occlusion device featuring two linear clamping portions that are parallel and overlap in their clamped position. A spring is integrated to bias these clamping portions toward this position, coupled with an endoscopic rein that facilitates the repositioning of the device toward an occlusion position where it can effectively interpose tissue.
The second patent pertains to a clamp assembly, which includes a clamping device biased toward a closed position along with two removably coupled retainer bars that are oriented in parallel. These innovations offer effective solutions in surgical settings, showcasing Resig's dedication to medical advancements.
Career Highlights: Philip P Resig has established himself as an invaluable member of Atricure, Inc., a company renowned for its commitment to developing innovative solutions for cardiac surgery. His work not only reflects his technical skill but also his dedication to improving surgical methodologies through reliable inventions.
Collaborations: Throughout his career, Resig has collaborated with notable coworkers such as James David Hughett, Sr., and Matthew Monti. Together, they contribute diverse expertise and perspectives, enhancing the innovation process and driving the development of groundbreaking medical devices.
Conclusion: Philip P Resig's contributions to the field of medical device innovation are commendable. His patents reflect a deep understanding of both technology and the needs of healthcare providers, illustrating his significant role in advancing tissue occlusion solutions. As he continues his work at Atricure, Inc., the medical community eagerly anticipates the future innovations that will emerge from his expertise and creativity.